NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,000 | +8.8% | 400 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $34,000 | +750.0% | 400 | +654.7% | 0.01% | +500.0% |
| Q1 2020 | $4,000 | -98.7% | 53 | -98.3% | 0.00% | -97.8% |
| Q4 2019 | $297,000 | +21.2% | 3,147 | +11.4% | 0.05% | +9.5% |
| Q3 2019 | $245,000 | -5.8% | 2,824 | -0.9% | 0.04% | -4.5% |
| Q2 2019 | $260,000 | -5.5% | 2,849 | -0.6% | 0.04% | -15.4% |
| Q1 2019 | $275,000 | -28.9% | 2,866 | -36.6% | 0.05% | -23.5% |
| Q4 2018 | $387,000 | -99.9% | 4,519 | +12.6% | 0.07% | +38.8% |
| Q3 2018 | $345,760,000 | +154257.1% | 4,013 | +34.9% | 0.05% | +40.0% |
| Q2 2018 | $224,000 | -6.7% | 2,974 | 0.0% | 0.04% | -14.6% |
| Q1 2018 | $240,000 | -13.0% | 2,974 | -9.7% | 0.04% | -14.6% |
| Q4 2017 | $276,000 | – | 3,295 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |